Halda HLD-0915-ONC-101 for metastatic APMS Prostate Cancer

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Phase 1/2 Study of HLD-0915 (JNJ-101556143) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Principal Investigator
Medical Assistant Professor in the Department of Medicine
Protocol Number
IRB: PRO00118104
NCT: NCT06800313
Phase
Phase I/II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL